PATENT CLAIM ANALYSIS

Application Number: 16260744
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-08
Patent Classification: ["544", "265000"]

Abstract:
The present invention relates to compounds of formula (I), wherein R 1 , R 2  and R 3  are as described herein, and their prodrugs or pharmaceutically acceptable salt, enantiomer or diastereomer thereof, and compositions including the compounds and methods of using the compounds.

Claim (Index 5):
A compound according to  claim 1 , wherein R 1  is ethyl.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 99.0
- Lexical Diversity: 1.37838
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15689136', '15148309', '15621080', '14958619', '13395429']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7913363825827883
- 35 USC 102 Novelty (BERT): 0.6315155054498909
- Combined Prediction Score: 0.7753542948694986
- Mean Citation Score: 438.6716619999999
- Max Citation Score: 698.61176
- Similarity Product: 510.3463720949936

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test